These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 28980001)
21. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. Khurana RN; Dupas B; Bressler NM Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027 [TBL] [Abstract][Full Text] [Related]
22. Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration. Ahmad I; Balasubramanian S; Del Debbio CB; Parameswaran S; Katz AR; Toris C; Fariss RN Invest Ophthalmol Vis Sci; 2011 May; 52(6):2868-78. PubMed ID: 21228388 [TBL] [Abstract][Full Text] [Related]
23. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling. Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605 [TBL] [Abstract][Full Text] [Related]
24. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related]
26. Displayed reflectivity of choroidal neovascular membranes by optical coherence tomography correlates with presence of leakage by fluorescein angiography. Giani A; Esmaili DD; Luiselli C; Cigada M; Salvetti P; Miller JW; Staurenghi G Retina; 2011 May; 31(5):942-8. PubMed ID: 21358457 [TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878 [TBL] [Abstract][Full Text] [Related]
28. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice. Kim KL; Suh W Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845 [TBL] [Abstract][Full Text] [Related]
29. Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse. Maestroni S; Maestroni A; Ceglia S; Tremolada G; Mancino M; Sacchi A; Lattanzio R; Zucchiatti I; Corti A; Bandello F; Zerbini G Acta Ophthalmol; 2015 May; 93(3):e218-22. PubMed ID: 25271003 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization. Song JH; Moon KY; Lee SC; Kim SS Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771 [TBL] [Abstract][Full Text] [Related]
32. Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration. Lee D; Nakai A; Miwa Y; Negishi K; Tomita Y; Kurihara T PeerJ; 2023; 11():e14611. PubMed ID: 36643635 [TBL] [Abstract][Full Text] [Related]
33. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization. Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073 [TBL] [Abstract][Full Text] [Related]
35. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone. Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Gu L; Chen H; Tuo J; Gao X; Chen L Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960 [TBL] [Abstract][Full Text] [Related]
37. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression. Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435 [TBL] [Abstract][Full Text] [Related]
38. The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration. Liang IC; Ko WC; Hsu YJ; Lin YR; Chang YH; Zong XH; Lai PC; Chang DC; Hung CF Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769482 [TBL] [Abstract][Full Text] [Related]
39. Effects of epoxyeicosatrienoic acids (EETs) on retinal macular degeneration in rat models. Mei F; Wang JG; Chen ZJ; Yuan ZL Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2970-2979. PubMed ID: 28682418 [TBL] [Abstract][Full Text] [Related]
40. Methallothionein-3 contributes to vascular endothelial growth factor induction in a mouse model of choroidal neovascularization. Choi JA; Hwang JU; Yoon YH; Koh JY Metallomics; 2013 Oct; 5(10):1387-96. PubMed ID: 23962989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]